Rituximab in Renal Allograft Recipients Who Develop Early De Novo Anti-HLA Alloantibodies
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Anil Chandraker, MD
Brigham and Women's Hospital
Study Chair - Mohamed H. Sayegh, MD
Brigham and Women's Hospital
Principal Investigator - William Harmon, MD
Boston Children's Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
17 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama
Birmingham, Alabama, United States
- University of Alabama, Pediatric Nephrology
Birmingham, Alabama, United States
- University of California, San Francisco
San Francisco, California, United States
- University of Florida
Gainesville, Florida, United States
- Northwestern University
Chicago, Illinois, United States
- University of Illinois
Chicago, Illinois, United States
- University of Maryland
Baltimore, Maryland, United States
- Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
- Brigham and Women'S Hospital
Boston, Massachusetts, United States
- Children'S Hospital Boston
Boston, Massachusetts, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- Saint Barnabas Medical Center
Livingston, New Jersey, United States
- Legacy Transplant Services
Portland, Oregon, United States
- Oregon Health Science University
Portland, Oregon, United States
- Children'S Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
- the Methodist Hospital
Houston, Texas, United States
- Children'S Hospital and Regional Medical Center
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2006
- Primary completion
- 31 Dec 2012
- Completion
- 31 Dec 2012
- Last update posted
- 23 Mar 2015
- Registered enrollment
- 757
- Registry id
- NCT00307125
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.